Scinai Immunotherapeutics Ltd.
SCNI· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 |
|---|---|---|
| Net Income | -$3.76M | -$2.98M |
| EPS Diluted | -$0.00 | -$0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Scinai Immunotherapeutics Ltd. · CIK 1611747 · Engraved from SEC EDGAR